Eton Pharmaceuticals (ETON) Net Cash Flow (2018 - 2025)
Eton Pharmaceuticals' Net Cash Flow history spans 7 years, with the latest figure at -$11.2 million for Q4 2025.
- On a quarterly basis, Net Cash Flow fell 109.93% to -$11.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $11.0 million, a 270.58% increase, with the full-year FY2025 number at $11.0 million, up 270.58% from a year prior.
- Net Cash Flow hit -$11.2 million in Q4 2025 for Eton Pharmaceuticals, down from $11.7 million in the prior quarter.
- Over the last five years, Net Cash Flow for ETON hit a ceiling of $11.7 million in Q3 2025 and a floor of -$11.2 million in Q4 2025.
- Historically, Net Cash Flow has averaged $197500.0 across 5 years, with a median of $663500.0 in 2022.
- Biggest five-year swings in Net Cash Flow: surged 22812.5% in 2022 and later tumbled 680.79% in 2024.
- Tracing ETON's Net Cash Flow over 5 years: stood at -$8.3 million in 2021, then skyrocketed by 135.25% to $2.9 million in 2022, then crashed by 123.3% to -$682000.0 in 2023, then tumbled by 680.79% to -$5.3 million in 2024, then tumbled by 109.93% to -$11.2 million in 2025.
- Business Quant data shows Net Cash Flow for ETON at -$11.2 million in Q4 2025, $11.7 million in Q3 2025, and $8.0 million in Q2 2025.